Spanish reformers call for bulk buying as a way to cut health costs
This article was originally published in Clinica
Under reforms proposed by the Spanish national health agency, Insalud, manufacturers are encouraged to offer lower prices in return for bulk purchasing by hospitals, when selling their products in the 11 regions administered by the agency.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.